Download Citation
Article Source:
Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins
Baeissa HM,
Bakhsh T,
Shakoori AM,
Sindi G,
Zaki RM,
et al.
(2026)
Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.
PLOS ONE 21(3): e0344592.
https://doi.org/10.1371/journal.pone.0344592